Obinutuzumab Can Be Administered as a 90-minute Short Duration Infusion in Patients With Previously Untreated Follicular Lymphoma: GAZELLE End of Induction Analysis.
- DOI
- 10.1097/hs9.0000000000000860
- Published
- 2023 Apr
- Container
- HemaSphere
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/hs9.0000000000000860,
title = {Obinutuzumab Can Be Administered as a 90-minute Short Duration Infusion in Patients With Previously Untreated Follicular Lymphoma: GAZELLE End of Induction Analysis.},
author = {Canales MA and Buchholz TA and Bortolini JAP and Fogliatto LM and Ishikawa T and Izutsu K and Salar A and Sharman JP and Klingbiel D and Pokala S and Vorozheikina E and Trask P and Parreira J and Hübel K},
year = {2023},
journal = {HemaSphere},
doi = {10.1097/hs9.0000000000000860},
url = {https://doi.org/10.1097/hs9.0000000000000860}
}RIS
TY - JOUR TI - Obinutuzumab Can Be Administered as a 90-minute Short Duration Infusion in Patients With Previously Untreated Follicular Lymphoma: GAZELLE End of Induction Analysis. AU - Canales MA AU - Buchholz TA AU - Bortolini JAP AU - Fogliatto LM AU - Ishikawa T AU - Izutsu K AU - Salar A AU - Sharman JP AU - Klingbiel D AU - Pokala S AU - Vorozheikina E AU - Trask P AU - Parreira J AU - Hübel K PY - 2023 JO - HemaSphere DO - 10.1097/hs9.0000000000000860 UR - https://doi.org/10.1097/hs9.0000000000000860 ER -
APA
MA, C., TA, B., JAP, B., LM, F., T, I., K, I., A, S., JP, S., D, K., S, P., E, V., P, T., J, P., & K, H. (2023). Obinutuzumab Can Be Administered as a 90-minute Short Duration Infusion in Patients With Previously Untreated Follicular Lymphoma: GAZELLE End of Induction Analysis.. HemaSphere. https://doi.org/10.1097/hs9.0000000000000860
Source records
- pubmed · retrieved 2026-09-26T07:02:40.988Z